Digoxin

Product manufactured by Sandoz Inc

Application Nr Approved Date Route Status External Links
ANDA040481 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Digoxin Injection Is A Cardiac Glycoside Indicated For: • Treatment Of Mild To Moderate Heart Failure In Adults. ( 1.1 ) • Increasing Myocardial Contractility In Pediatric Patients With Heart Failure. ( 1.2 ) • Control Of Resting Ventricular Rate In Adults With Chronic Atrial Fibrillation. ( 1.3 ) 1.1 Heart Failure In Adults Digoxin Injection Is Indicated For The Treatment Of Mild To Moderate Heart Failure In Adults. Digoxin Injection Increases Left Ventricular Ejection Fraction And Improves Heart Failure Symptoms, As Evidenced By Improved Exercise Capacity And Decreased Heart Failure-Related Hospitalizations And Emergency Care, While Having No Effect On Mortality. Where Possible, Digoxin Injection Should Be Used In Combination With A Diuretic And An Angiotensin-Converting Enzyme (Ace) Inhibitor. 1.2 Heart Failure In Pediatric Patients Digoxin Injection Increases Myocardial Contractility In Pediatric Patients With Heart Failure. 1.3 Atrial Fibrillation In Adults Digoxin Injection Is Indicated For The Control Of Ventricular Response Rate In Adult Patients With Chronic Atrial Fibrillation.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Digoxin

Comments